Envestnet Asset Management
ELDN icon

Envestnet Asset Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Envestnet Asset Management’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,726
Closed -$66K – 3954
2022
Q1 		$66K Hold
16,726
– – ﹤0.01% 3838
2021
Q4 		$74K Hold
16,726
– – ﹤0.01% 3787
2021
Q3 		$103K Buy
+16,726
New +$117K ﹤0.01% 3584

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Envestnet Asset Management's ELDN Position: Q2 2022 in Review

Envestnet Asset Management sold out of Eledon Pharmaceuticals (ELDN) in Q2 2022, closing a stake of 16,726 shares — an estimated $66K sold.

Envestnet Asset Management first reported a position in ELDN in Q3 2021 and held it in 3 quarters. The position peaked at $103K in Q3 2021. 31 funds tracked by Wall St. Rank hold ELDN as of Q2 2022.

  • Envestnet Asset Management reported no remaining Eledon Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Envestnet Asset Management sold 16,726 Eledon Pharmaceuticals shares in Q2 2022, an estimated $66K.
  • Envestnet Asset Management first reported a position in Eledon Pharmaceuticals in Q3 2021 and held it in 3 quarters.
  • Envestnet Asset Management's Eledon Pharmaceuticals position peaked at $103K in Q3 2021.
  • 31 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2022.

Based on Envestnet Asset Management's 13F filing for Q2 2022, filed 3 Aug 2022.